◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

CARGO THERAPEUTICS, INC.

CIK: 1966494 SIC: 2836
-
Revenue
$-221.78M
Net Income
-
Gross Margin
-
Op. Margin
$-297.82M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 6 of 6 quarterly reports available
Breakdown Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Operating Expenses $52.90M $88.42M $50.13M $47.11M $49.32M $40.81M
Research & Development $7.51M $30.64M $39.50M $35.93M $37.46M $30.50M
Operating Income $-52.90M $-88.42M $-50.13M $-47.11M $-49.32M $-40.81M
Interest Income $3.27M $3.94M $4.67M $5.40M $4.99M $5.00M
Other Income/Expense $-307.00K $-11.00K $31.00K $-199.00K $-17.00K $-10.00K
Net Income $-49.94M $-84.50M $-45.44M $-41.91M $-44.35M $-35.81M
Basic EPS -1.04 -1.77 -0.95 -0.88 -1.02 -0.87
Diluted EPS -1.04 -1.77 -0.95 -0.88 -1.02 -0.87
Basic Shares Outstanding 48.1M 47.9M 955K 47.7M 43.3M 41.0M
Diluted Shares Outstanding 48.1M 47.9M 955K 47.7M 43.3M 41.0M
Breakdown Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Cash & Cash Equivalents $107.75M $61.77M $64.38M $71.18M $153.58M $81.53M
Short-term Investments $144.82M $257.07M $275.32M $333.67M $289.90M $294.39M
Other Current Assets $4.99M $4.40M $5.31M $5.17M $4.62M $4.04M
Total Current Assets $258.61M $324.81M $345.01M $410.02M $448.10M $379.95M
Property Plant & Equipment - $1.11M $11.29M $11.66M $11.84M $10.61M
Long-term Investments - $12.44M $28.39M - - -
Other Non-current Assets - $93.00K $5.31M $4.65M $4.38M $4.38M
Total Assets $258.61M $361.96M $414.05M $450.96M $490.01M $422.43M
Accounts Payable $8.67M $4.23M $2.44M $5.37M $7.01M $7.17M
Total Current Liabilities $20.91M $51.55M $25.03M $21.64M $26.42M $22.65M
Total Liabilities $20.91M $79.50M $53.83M $50.08M $53.91M $49.22M
Common Stock $46.00K $46.00K $46.00K $46.00K $46.00K $39.00K
Retained Earnings $-447.08M $-397.15M $-312.65M $-267.21M $-225.31M $-180.96M
Total Stockholders Equity $237.70M $282.46M $360.23M $400.88M $436.10M $373.21M
Total Liabilities & Equity $258.61M $361.96M $414.05M $450.96M $490.01M $422.43M
Breakdown Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Net Income $-134.44M $-84.50M $-45.44M $-122.07M $-80.16M $-35.81M
Stock-based Compensation $12.13M $6.88M $4.83M $13.14M $8.21M $3.90M
Change in Payables $6.53M $1.60M $-3.15M $1.05M $2.32M $2.67M
Operating Cash Flow $-115.08M $-37.69M $-34.89M $-104.86M $-65.23M $-30.15M
Capital Expenditure $481.00K $382.00K $630.00K $3.82M $2.75M $1.29M
Purchases of Investments $81.69M $81.69M $115.41M $489.46M $360.38M $292.34M
Investing Cash Flow $158.40M $35.04M $28.27M $-333.35M $-290.17M $-293.96M
Financing Cash Flow $43.00K $38.00K $-178.00K $103.65M $103.25M $-104.00K
Net Change in Cash $43.37M $-2.61M $-6.80M $-334.56M $-252.15M $-324.21M
SEC Filing Format - Data shown as it appears in the Q2 2025 (10-Q) filing Period ended: Jun 30, 2025
Condensed Consolidated Statements of Operations
Description Jun 30, 2025 Jun 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $52.90M - $141.32M -
Research & Development $7.51M - $38.15M -
Operating Income $-52.90M - $-141.32M -
Interest Income $3.27M - $7.21M -
Other Income/Expense $-307.00K - $-318.00K -
Net Income $-49.94M $-35.81M $-134.44M -
Basic EPS -1.04 - -2.80 -
Diluted EPS -1.04 - -2.80 -
Basic Shares Outstanding $48.13M - $47.99M -
Diluted Shares Outstanding $48.13M - $47.99M -
Condensed Consolidated Balance Sheets
Description Jun 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $107.75M $64.38M
Short-term Investments $144.82M $275.32M
Other Current Assets $4.99M $5.31M
Total Current Assets $258.61M $345.01M
Property Plant & Equipment - $11.29M
Long-term Investments - $28.39M
Other Non-current Assets - $5.31M
Total Assets $258.61M $414.05M
Accounts Payable $8.67M $2.44M
Total Current Liabilities $20.91M $25.03M
Total Liabilities $20.91M $53.83M
Common Stock $46.00K $46.00K
Retained Earnings $-447.08M $-312.65M
Total Stockholders Equity $237.70M $360.23M
Total Liabilities & Equity $258.61M $414.05M
Condensed Consolidated Statements of Cash Flows
Description Jun 30, 2025 Jun 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-49.94M $-35.81M $-134.44M -
Stock-based Compensation - - $12.13M -
Change in Payables - - $6.53M -
Operating Cash Flow - - $-115.08M -
Capital Expenditure - - $481.00K -
Purchases of Investments - - $81.69M -
Investing Cash Flow - - $158.40M -
Financing Cash Flow - - $43.00K -
Net Change in Cash - - $43.37M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...